Gene therapy of human somatotroph and lactotroph pituitary adenomas using an adenoviral virus expressing the somatostatin receptor type 2

被引：0
|
作者：
Acunzo, Julie [1 ]
Roche, Catherine [1 ]
Thirion, Sylvie [1 ]
Saveanu, Alexandru [1 ]
Gunz, Ginette [1 ]
Germanetti, Anne Laure [2 ]
Couderc, Bettina [3 ]
Brue, Thierry [4 ]
Enjalbert, Alain [1 ]
Barlier, Anne [1 ]
机构：
[1] Univ Aix Marseille 2, CNRS, UMR 6231, Marseille, France
[2] Ctr Hosp Univ Concept, Lab Biochim & Biol Mol, Marseille, France
[3] Univ Toulouse, Inst Claudius Regaud, Toulouse, France
[4] Ctr Hosp Univ Timone, Dept Endocrinol, Marseille, France
来源：
HUMAN GENE THERAPY | 2008年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1107 / 1107
页数：1
相关论文
共 50 条
  • [11] Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas
    Acunzo, Julie
    Thirion, Sylvie
    Roche, Catherine
    Saveanu, Alexandru
    Gunz, Ginette
    Germanetti, Anne Laure
    Couderc, Bettina
    Cohen, Richard
    Figarella-Branger, Dominique
    Dufour, Henry
    Brue, Thierry
    Enjalbert, Alain
    Barlier, Anne
    CANCER RESEARCH, 2008, 68 (24) : 10163 - 10170
  • [12] PET/CT imaging of human somatostatin receptor 2 (hsstr2) as reporter gene for gene therapy
    Hofmann, M.
    Gazdhar, A.
    Weitzel, T.
    Schmid, R.
    Krause, T.
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2006, 569 (02): : 509 - 511
  • [13] Impact of gsp oncogene on the expression of genes coding for Gsα, Pit-1, Gi2α, and somatostatin receptor 2 in human somatotroph adenomas:: Involvement in octreotide sensitivity
    Barlier, A
    Pellegrini-Bouiller, I
    Gunz, G
    Zamora, AJ
    Jaquet, P
    Enjalbert, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08): : 2759 - 2765
  • [14] Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: A possible marker for predicting long-term response to octreotide therapy
    Yoshihara, Ai
    Isozaki, Osamu
    Hizuka, Naomi
    Nozoe, Yasuko
    Harada, Chie
    Ono, Masami
    Kawamata, Takakazu
    Kubo, Osami
    Hori, Tomokatsu
    Takano, Kazue
    ENDOCRINE JOURNAL, 2007, 54 (01) : 133 - 138
  • [15] Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas - Novel potential therapy for functional pituitary tumors
    Shimon, I
    Yan, XM
    Taylor, JE
    Weiss, MH
    Culler, MD
    Melmed, S
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09): : 2386 - 2392
  • [16] Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene
    Verwijnen, SM
    Smith, PAES
    Hoeben, RC
    Rabelink, MJWE
    Wiebe, L
    Curiel, DT
    Hemminki, A
    Krenning, EP
    de Jong, M
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (01) : 111 - 120
  • [17] Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2:: Molecular imaging after systemic delivery using 111In-Pentetreotide
    McCart, JA
    Mehta, N
    Scollard, D
    Reilly, RM
    Carrasquillo, JA
    Tang, N
    Deng, H
    Miller, M
    Xu, H
    Libutti, SK
    Alexander, HR
    Bartlett, DL
    MOLECULAR THERAPY, 2004, 10 (03) : 553 - 561
  • [18] The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction
    Neyrinck, Katrien
    Breuls, Natacha
    Holvoet, Bryan
    Oosterlinck, Wouter
    Wolfs, Esther
    Vanbilloen, Hubert
    Gheysens, Olivier
    Duelen, Robin
    Gsell, Willy
    Lambrichts, Ivo
    Himmelreich, Uwe
    Verfaillie, Catherine M.
    Sampaolesi, Maurilio
    Deroose, Christophe M.
    THERANOSTICS, 2018, 8 (10): : 2799 - 2813
  • [19] Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
    M Filopanti
    A M Barbieri
    A R Angioni
    A Colao
    V Gasco
    S Grottoli
    A Peri
    S Baglioni
    M F Fustini
    F Pigliaru
    P D Monte
    G Borretta
    B Ambrosi
    M L Jaffrain-Rea
    M Gasperi
    S Brogioni
    S Cannavò
    G Mantovani
    P Beck-Peccoz
    A Lania
    A Spada
    The Pharmacogenomics Journal, 2008, 8 : 357 - 363
  • [20] Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
    Filopanti, M.
    Barbieri, A. M.
    Angioni, A. R.
    Colao, A.
    Gasco, V.
    Grottoli, S.
    Peri, A.
    Baglioni, S.
    Fustini, M. F.
    Pigliaru, F.
    Monte, P. D.
    Borretta, G.
    Ambrosi, B.
    Jaffrain-Rea, M. L.
    Gasperi, M.
    Brogioni, S.
    Cannavo, S.
    Mantovani, G.
    Beck-Peccoz, P.
    Lania, A.
    Spada, A.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (05): : 357 - 363
12345